111 related articles for article (PubMed ID: 35021982)
1. Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia.
Barbieri MA; Bagnato G; Ioppolo C; Versace AG; Irrera N
CNS Neurol Disord Drug Targets; 2022; 21(10):1017-1026. PubMed ID: 35021982
[TBL] [Abstract][Full Text] [Related]
2. The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis-A Preliminary Report.
Satheesh NJ; Salloum-Asfar S; Abdulla SA
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696521
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Invasion and Pathological Links to Prion Disease.
Lukiw WJ; Jaber VR; Pogue AI; Zhao Y
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139092
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and Alzheimer's disease: Impact of lockdown and other restrictive measures during the COVID-19 pandemic.
Nawaz AD; Haider MZ; Akhtar S
Biomol Biomed; 2024 Mar; 24(2):219-229. PubMed ID: 38078809
[TBL] [Abstract][Full Text] [Related]
5. The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis.
Dziedzic A; Saluk-Bijak J; Miller E; Niemcewicz M; Bijak M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670394
[TBL] [Abstract][Full Text] [Related]
6. COVID-19: dealing with a potential risk factor for chronic neurological disorders.
Schirinzi T; Landi D; Liguori C
J Neurol; 2021 Apr; 268(4):1171-1178. PubMed ID: 32852580
[TBL] [Abstract][Full Text] [Related]
7. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?
Verkhratsky A; Li Q; Melino S; Melino G; Shi Y
Biol Direct; 2020 Nov; 15(1):28. PubMed ID: 33246479
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Infection to Premature Neuronal Aging and Neurodegenerative Diseases: Is there any Connection with Hypoxia?
Sivagurunathan N; Calivarathan L
CNS Neurol Disord Drug Targets; 2024; 23(4):431-448. PubMed ID: 37073650
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2-Mediated Neuropathogenesis, Deterioration of Hippocampal Neurogenesis and Dementia.
Radhakrishnan RK; Kandasamy M
Am J Alzheimers Dis Other Demen; 2022; 37():15333175221078418. PubMed ID: 35133907
[TBL] [Abstract][Full Text] [Related]
10. Chronic neurological diseases and COVID-19: Associations and considerations.
Meshkat S; Salimi A; Joshaghanian A; Sedighi S; Sedighi S; Aghamollaii V
Transl Neurosci; 2020; 11(1):294-301. PubMed ID: 33335769
[TBL] [Abstract][Full Text] [Related]
11. Molecular cross-talk between long COVID-19 and Alzheimer's disease.
Pszczołowska M; Walczak K; Misków W; Antosz K; Batko J; Karska J; Leszek J
Geroscience; 2024 Jun; 46(3):2885-2899. PubMed ID: 38393535
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?
McAlpine LS; Fesharaki-Zadeh A; Spudich S
Curr Opin Psychiatry; 2021 Mar; 34(2):177-185. PubMed ID: 33395100
[TBL] [Abstract][Full Text] [Related]
13. Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment.
Zhao J; Xia F; Jiao X; Lyu X
Front Neurol; 2024; 15():1367974. PubMed ID: 38638307
[TBL] [Abstract][Full Text] [Related]
14. The Potential Role of SARS-COV-2 in the Pathogenesis of Parkinson's Disease.
Chaná-Cuevas P; Salles-Gándara P; Rojas-Fernandez A; Salinas-Rebolledo C; Milán-Solé A
Front Neurol; 2020; 11():1044. PubMed ID: 33041985
[TBL] [Abstract][Full Text] [Related]
15. Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia.
D'Arrigo JS
Am J Alzheimers Dis Other Demen; 2020; 35():1533317520976761. PubMed ID: 33307726
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 on Alzheimer's Disease Risk: Viewpoint for Research Action.
Abate G; Memo M; Uberti D
Healthcare (Basel); 2020 Aug; 8(3):. PubMed ID: 32839380
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Review of Neurodegenerative Manifestations of SARS-CoV-2.
Bedran D; Bedran G; Kote S
Vaccines (Basel); 2024 Feb; 12(3):. PubMed ID: 38543856
[TBL] [Abstract][Full Text] [Related]
18. Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium.
Bhaskar S; Bradley S; Israeli-Korn S; Menon B; Chattu VK; Thomas P; Chawla J; Kumar R; Prandi P; Ray D; Golla S; Surya N; Yang H; Martinez S; Ozgen MH; Codrington J; González EMJ; Toosi M; Hariya Mohan N; Menon KV; Chahidi A; Mederer Hengstl S
Front Neurol; 2020; 11():664. PubMed ID: 32695066
[TBL] [Abstract][Full Text] [Related]
19. Severe infections as a gateway to dementia.
Kivimäki M; Walker KA
Nat Aging; 2024 Jun; 4(6):752-754. PubMed ID: 38783151
[No Abstract] [Full Text] [Related]
20. COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
Amadoro G; Latina V; Stigliano E; Micera A
Cells; 2023 Nov; 12(22):. PubMed ID: 37998336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
